J Hepatol:门静脉高压相关出血的肝硬化患者都应该实施早期TIPS吗?

2017-09-21 MedSci MedSci原创

结论:1/3的肝硬化患者满足实施早期TIPS的标准,然而,仅仅7%的患者可以实施早期TIPS。临床上,早期TIPS适合肝硬化病情较轻的患者。肝脏疾病严重程度是唯一影响生存率的参数。


背景:Baveno VI共识会议得出结论,有静脉曲张出血(VB)的高危肝硬化患者(Child B +内镜下出血或者Child C10-13的患者)必须考虑早期经颈静脉肝内门体静脉内支架分流术(TIPS)。然而,这种治疗方案在临床工作中是否可行,目前尚不清楚。

目的:(1)判断在静脉曲张出血的肝硬化患者中适合实施TIPS的患者比例。(2)在适合实施TIPS的患者中,接受早期TIPS患者的比例以及拒绝TIPS的主要原因。(3)实施早期TIPS患者的临床效果。

材料和方法:该研究是一项大型、全国性、前瞻性、多中心(包括学术型和非学术型中心)的研究。邀请法国所有招募胃肠道出血患者的研究中心参与此项大型研究。招募肝硬化和PHT相关出血患者的所有研究中心被包括在内。

研究结果:此项研究纳入964例患者[58个研究中心:26个学术型中心,32个非学术型研究中心;患者特征:男性,77%;年龄59.6±12.1岁;肝硬化病因(酒精,病毒,其他,67%/15%/18%);出血来源(食管静脉曲张出血/胃静脉曲张出血/其他, 80/11/9%);内镜下所见活跃出血所占比例为34%;ChildA,B,C级所占的比例分别为21%,44%,35%]。总体上说,35%的患者达到了上述实施早期TIPS的标准,然而,仅仅6.8%的肝硬化病情较轻的患者实施了早期TIPS。拒绝实施早期TIPS的主要原因是缺乏可适用性。术后一年,实施早期TIPS患者的生存率显著增加(85.7+/-0.07% vs 58.9+/-0.03%, p=0.04)。肝病的严重程度是唯一与一年生存率增高的有关参数。

结论:1/3的肝硬化患者满足实施早期TIPS的标准,然而,仅仅7%的患者可以实施早期TIPS。临床上,早期TIPS适合肝硬化病情较轻的患者。肝脏疾病严重程度是唯一影响生存率的参数。

原始出处:

Thabut D, Pauwels A, Carbonell N, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol, 2017, Sep 13. doi: 10.1016/j.jhep.2017.09.002.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697544, encodeId=1133169e54469, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Sep 04 07:56:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643002, encodeId=23711643002e9, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Wed Jul 18 06:56:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377752, encodeId=ddc913e775225, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426843, encodeId=6d75142684360, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435150, encodeId=35d314351501f, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=)]
    2018-09-04 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697544, encodeId=1133169e54469, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Sep 04 07:56:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643002, encodeId=23711643002e9, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Wed Jul 18 06:56:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377752, encodeId=ddc913e775225, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426843, encodeId=6d75142684360, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435150, encodeId=35d314351501f, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=)]
    2018-07-18 yige2011
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697544, encodeId=1133169e54469, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Sep 04 07:56:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643002, encodeId=23711643002e9, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Wed Jul 18 06:56:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377752, encodeId=ddc913e775225, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426843, encodeId=6d75142684360, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435150, encodeId=35d314351501f, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=)]
    2017-09-23 chengjn
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697544, encodeId=1133169e54469, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Sep 04 07:56:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643002, encodeId=23711643002e9, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Wed Jul 18 06:56:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377752, encodeId=ddc913e775225, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426843, encodeId=6d75142684360, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435150, encodeId=35d314351501f, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=)]
    2017-09-23 gwc384
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697544, encodeId=1133169e54469, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Sep 04 07:56:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643002, encodeId=23711643002e9, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Wed Jul 18 06:56:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377752, encodeId=ddc913e775225, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426843, encodeId=6d75142684360, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435150, encodeId=35d314351501f, content=<a href='/topic/show?id=6d779e14916' target=_blank style='color:#2F92EE;'>#门静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97149, encryptionId=6d779e14916, topicName=门静脉)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 23 01:56:00 CST 2017, time=2017-09-23, status=1, ipAttribution=)]

相关资讯

J Viral Hepat:HIV感染的患者中,细菌移位和HCV相关肝硬化的临床进展

总而言之,细菌移位似乎不是预测HIV合并HCV感染的肝硬化患者临床结局的预测指标。

Gut:在发生感染的肝硬化患者中评估Sepsis-3和q SOFA标准的预测能力

在预测肝硬化患者感染严重程度时,Sepsis-3标准比SIRS标准更准确。qSOFA是一有用的床边工具,可以评估患者不良临床结局的风险。发生败血症、有快速序贯器官衰竭倾向的患者应该加强管理,严格监控。

Am J Gastroenterol:Fibrosis-4指数有助于确定慢性乙型肝炎患者肝癌风险

慢性乙型肝炎病毒感染的非肝硬化患者,当FIB-4<1.29时,发生肝细胞癌的风险最小。

Gastroenterology:抗凝药使肝硬化合并门静脉血栓患者受益良多

2017年8月,发表在《Gastroenterology》的一项由意大利科学家进行的系统评价和荟萃分析,考察了抗凝药在肝硬化合并门静脉血栓(PVT)患者中的效果。

Liver Int:细菌性感染引起的慢性肝功能衰竭与死亡率增加有关

总之,研究表明,欧洲肝病学会-慢性肝衰竭-合作组(EASL-CLIF-Consortium)提出的ACLF是肝硬化急性失代偿患者死亡率的有力预测因子。然而,相比那些未感染的患者,感染引发的ACLF患者死亡率显著增加。

Hepatology:心血管参数独立预测肝硬化患者的死亡风险

研究表明,经过长期随访,MELD、年龄和BSA是肝硬化患者死亡的主要预测因素。在心血管参数方面,左心房增大,心率增加,E/e',平均血压降低,是死亡独立的预测因素。